Open AccessSimplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial
Author(s) -
D.A. Wohl,
L. Bhatti,
C.B. Small,
H. Edelstein,
H.H. Zhao,
D.A. Margolis,
E. DeJesus,
W.G. Weinberg,
L.L. Ross,
M.S. Shaefer
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1n60-2634
Subject(s) - atazanavir , abacavir , lamivudine , medicine , tenofovir , virology , pharmacology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , virus , hepatitis b virus